Sections

Weather Forecast

Close
Advertisement

Area physicians accept thousands from drug companies for speaking, other expenses

Email

In 2010, pharmaceutical company Novartis paid Grand Forks neurologist Dr. Matthew Roller $4,550 to talk about its drug Gilenya, the first oral medication approved for treating multiple sclerosis.

Before that medication, multiple sclerosis was treated via injection — a method patients weren’t fond of, according to Roller.

Get the full story
Subscribe or Log In

Are you a newspaper subscriber but you don't have a Digital Access account yet? Activate your account.

You will need your subscription account number and phone number. Not sure if you have an account? Email us or call (701) 780-1100 and we can help you.

Advertisement
Brandi Jewett
Brandi Jewett is an enterprise reporter for the Grand Forks Herald and reports on a variety of topics. Other positions she has held at the Herald include city government reporter, general assigment reporter and news intern. She also serves as an alumni adviser to UND's Dakota Student newspaper. A native of Valley City, N.D., 24 years worth of winters haven't scared her out of the state yet.
(701) 780-1108
Advertisement
Advertisement